Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1974 1
1975 6
1976 7
1977 9
1978 2
1979 3
1980 9
1981 6
1982 17
1983 14
1984 13
1985 14
1986 10
1987 13
1988 14
1989 23
1990 28
1991 29
1992 43
1993 47
1994 31
1995 39
1996 44
1997 59
1998 55
1999 47
2000 61
2001 57
2002 79
2003 71
2004 64
2005 73
2006 84
2007 82
2008 97
2009 106
2010 112
2011 122
2012 147
2013 141
2014 174
2015 119
2016 130
2017 140
2018 158
2019 157
2020 214
2021 231
2022 232
2023 196
2024 186
2025 184
2026 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,599 results

Results by year

Filters applied: . Clear all
Page 1
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.
Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Antón J, Belot A, Bracaglia C, Constantin T, Dagna L, Di Bartolo A, Feist E, Foell D, Gattorno M, Georgin-Lavialle S, Giacomelli R, Grom AA, Jamilloux Y, Laskari K, Lazar C, Minoia F, Nigrovic PA, Oliveira Ramos F, Ozen S, Quartier P, Ruscitti P, Sag E, Savic S, Truchetet ME, Vastert SJ, Wilhelmer TC, Wouters C, Carmona L, De Benedetti F. Fautrel B, et al. Ann Rheum Dis. 2024 Nov 14;83(12):1614-1627. doi: 10.1136/ard-2024-225851. Ann Rheum Dis. 2024. PMID: 39317417 Free PMC article.
Systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) are considered the same disease, but a common approach for diagnosis and management is still missing. ...CONCLUSION: These recommendations …
Systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) are co …
A comprehensive review on adult onset Still's disease.
Giacomelli R, Ruscitti P, Shoenfeld Y. Giacomelli R, et al. J Autoimmun. 2018 Sep;93:24-36. doi: 10.1016/j.jaut.2018.07.018. Epub 2018 Aug 1. J Autoimmun. 2018. PMID: 30077425 Review.
Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology usually affecting young adults; spiking fever, arthritis and evanescent rash are commonly observed during the disease. ...Despite thi …
Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology usually affect …
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Efthimiou P, et al. Semin Arthritis Rheum. 2021 Aug;51(4):858-874. doi: 10.1016/j.semarthrit.2021.06.004. Epub 2021 Jun 13. Semin Arthritis Rheum. 2021. PMID: 34175791 Free article. Review.
BACKGROUND: Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown etiology, characterized by a clinical triad of high spiking fever, arthralgia ( arthritis), and evanescent skin rash. ...In this review, w …
BACKGROUND: Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown etiolo …
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease.
De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S. De Matteis A, et al. Ann Rheum Dis. 2024 Nov 14;83(12):1748-1761. doi: 10.1136/ard-2024-225853. Ann Rheum Dis. 2024. PMID: 39317414 Free PMC article.
OBJECTIVES: To analyse the similarity in clinical manifestations and laboratory findings between systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD). METHODS: Three systematic reviews (SR) were perf …
OBJECTIVES: To analyse the similarity in clinical manifestations and laboratory findings between systemic juvenile idiopathic arth …
Recent advances and evolving concepts in Still's disease.
Ruscitti P, Cantarini L, Nigrovic PA, McGonagle D, Giacomelli R. Ruscitti P, et al. Nat Rev Rheumatol. 2024 Feb;20(2):116-132. doi: 10.1038/s41584-023-01065-6. Epub 2024 Jan 11. Nat Rev Rheumatol. 2024. PMID: 38212542 Review.
Still's disease is a rare inflammatory syndrome that encompasses systemic juvenile idiopathic arthritis and adult-onset Still's disease, both of which can exhibit life-threatening complications, including macro …
Still's disease is a rare inflammatory syndrome that encompasses systemic juvenile idiopathic arthritis a …
Juvenile idiopathic arthritis.
Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, Ruperto N. Martini A, et al. Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8. Nat Rev Dis Primers. 2022. PMID: 35087087 Free article. Review.
Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting for >6 weeks with onset before 16 years of age. ...According to the International League Against Rheumatism (ILAR) classification, seven mutually …
Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting for >6 weeks with …
Canakinumab for the treatment of adult-onset Still's disease.
Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P. Sfriso P, et al. Expert Rev Clin Immunol. 2020 Feb;16(2):129-138. doi: 10.1080/1744666X.2019.1707664. Epub 2020 Jan 18. Expert Rev Clin Immunol. 2020. PMID: 31957508 Review.
Introduction: Adult-onset Still's disease (AOSD) is a rare multisystem autoinflammatory disorder of unknown etiology, with clinical and biological similarities with the juvenile form (sJIA).The pivotal role of interleukin (IL)-1 gives ris …
Introduction: Adult-onset Still's disease (AOSD) is a rare multisystem autoinflammatory disorder of unkno …
Biologics for the treatment of adult-onset still's disease.
Yoo DH. Yoo DH. Expert Opin Biol Ther. 2019 Nov;19(11):1173-1190. doi: 10.1080/14712598.2019.1652591. Epub 2019 Aug 14. Expert Opin Biol Ther. 2019. PMID: 31379214 Review.
Introduction: Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology, and approximately 60-70% of patients develop a chronic form. ...Area Covered: Due to rarity and heterogeneous features of the disease …
Introduction: Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology, …
[Update on Adult-Onset Still's Disease: Diagnosis, Therapy and Guideline].
Vordenbäumen S, Feist E. Vordenbäumen S, et al. Dtsch Med Wochenschr. 2023 Jun;148(12):788-792. doi: 10.1055/a-2000-3446. Epub 2023 May 31. Dtsch Med Wochenschr. 2023. PMID: 37257482 German.
Adult-onset Still's disease (ASOD) is an autoinflammatory disease of unknown etiology which is pathogenetically characterized by an involvement of the innate immune response with activation of neutrophils and an increased secretion of IL- …
Adult-onset Still's disease (ASOD) is an autoinflammatory disease of unknown etiology which is pat …
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Gillard L, Pouchot J, Cohen-Aubart F, Koné-Paut I, Mouterde G, Michaud M, Reumaux H, Savey L, Belot A, Fautrel B, Mitrovic S. Gillard L, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):1594-1604. doi: 10.1093/rheumatology/keac440. Rheumatology (Oxford). 2023. PMID: 35920788
OBJECTIVES: Excessive and inappropriate production of pro-inflammatory cytokines plays a key role in Still's disease. Janus kinase inhibitor (JAKi) agents mainly block pro-inflammatory cytokine pathways, notably IL-6 and IFN. ...CONCLUSION: JAKi agents may be …
OBJECTIVES: Excessive and inappropriate production of pro-inflammatory cytokines plays a key role in Still's disease. J …
3,599 results